Merck, Daiichi Sankyo withdraw US application for lung cancer drug

Merck NYSE:MRK and Daiichi Sankyo TSE:4568 have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the drugmakers said on Friday.